A further 10–15 % of neonates with Down syndrome have one or more acquired GATA1 mutations in association with a low number of circulating blast cells (<10 %) and have clinically and haematologically silent disease (silent TAM) [11••]. The gene discussed is GATA1; the disease is Down syndrome.